SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Medical Care Costs Associated with Cancer Survivorship in the United States
4 references·14 citing·30 second hop
Medical Care Costs Associated with Cancer Survivorship in the United States (2020)Medical Care Costs Associated with Cancer…Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received (2016)Updating the American Society…American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)American Society of Clinical …Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Projections of the Cost of Ca…Cost of Care for Elderly Cancer Patients in the United States (2008)Cost of Care for Elderly Canc…The Intersection of Spirituality, Religiosity, and Lifestyle Practices in Religious Communities to Successful Aging: A Review Article (2024)The Intersection of Spiritual…The Financial Burden of Localized and Metastatic Bladder Cancer (2024)The Financial Burden of Local…The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review (2023)The social vulnerability inde…Racial disparity and regional variance in healthcare utilization among patients with lung cancer in US hospitals during 2016–2019 (2023)Racial disparity and regional…Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions (2023)Financial Toxicity in Cancer …Disparities in Neuro-Oncology (2023)Disparities in Neuro-OncologyArea-level Socioeconomic Disadvantage and Cancer Survival in Metropolitan Detroit (2023)Area-level Socioeconomic Disa…Navigating financial toxicity in patients with cancer: A multidisciplinary management approach (2022)Navigating financial toxicity…Increased healthcare costs by later stage cancer diagnosis (2022)Increased healthcare costs by…Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019 (2022)Cancer Therapy Approval Timin…Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−2030 (2021)Population-level economic bur…Financial toxicity in cancer care: origins, impact, and solutions (2021)Financial toxicity in cancer …Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes (2021)Association of Participation …Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care (2021)Annual Report to the Nation o…Net Health Benefits (1998)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Essential medicines for universal health coverage (2016)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)The Distinction Between Cost and Charges (1982)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors (2018)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis (2020)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Addressing Transportation Insecurity Among Patients With Cancer (2022)Spatial accessibility of primary care: concepts, methods and challenges (2004)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Social determinants of health, workforce diversity, and financial toxicity: A review of disparities in cancer care (2022)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Global prevalence of poor sleep quality in cancer patients: A systematic review and meta-analysis (2023)ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer (2024)Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research (2011)Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. (2016)Global treatment costs of breast cancer by stage: A systematic review (2018)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2008)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Social Vulnerability and Receipt of Guideline-Concordant Care among Patients with Colorectal Cancer (2024)Impact of Social Determinants of Health on Cardiovascular Disease (2025)Delivering affordable cancer care in high-income countries (2011)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)Association Between Social Determinants of Health and Cancer Treatment Delay in an Urban Population (2024)
this work references cited by second hop

References

  • 2011Projections of the Cost of Cancer Care in the United States: 2010-20202,653 cited
  • 2015American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options916 cited
  • 2008Cost of Care for Elderly Cancer Patients in the United States700 cited
  • 2016Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received655 cited

Cited by

  • 2022Navigating financial toxicity in patients with cancer: A multidisciplinary management approach264 cited
  • 2021Financial toxicity in cancer care: origins, impact, and solutions252 cited
  • 2021Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care210 cited
  • 2023Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions122 cited
  • 2022Increased healthcare costs by later stage cancer diagnosis107 cited
  • 2023The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review103 cited
  • 2024The Financial Burden of Localized and Metastatic Bladder Cancer88 cited
  • 2022Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-201983 cited
  • 2021Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

76 cited
  • 2021Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−203068 cited
  • 2023Area-level Socioeconomic Disadvantage and Cancer Survival in Metropolitan Detroit25 cited
  • 2023Disparities in Neuro-Oncology24 cited
  • 2024The Intersection of Spirituality, Religiosity, and Lifestyle Practices in Religious Communities to Successful Aging: A Review Article14 cited
  • 2023Racial disparity and regional variance in healthcare utilization among patients with lung cancer in US hospitals during 2016–201913 cited